feed,title,long_url,short_url
Benzinga,"Mustang Bio's CAR T Cell Therapy Achieves 93% ORR, 67% CR In Mid-Stage Leukemia Trial",https://benzinga.com/news/21/06/21526339/mustang-bios-car-t-cell-therapy-achieves-93-orr-67-cr-in-mid-stage-leukemia-trial,https://j.mp/2TUmg3X
Benzinga,Novan's Stock Surges As SB206 Can Potentially Shorten Duration Of Contagious Skin Disease,https://benzinga.com/general/biotech/21/06/21526018/novans-stock-surges-as-sb206-can-potentially-shorten-duration-of-contagious-skin-disease,https://j.mp/3cwLL1W
